Rucaparib Delays Next Lines of Therapy in Ovarian Cancer Christos Evangelou, MSc, PhD June 23, 2026

https://www.medscape.com/viewarticle/rucaparib-delays-next-lines-therapy-ovarian-cancer-2026a1000l58?src= For patients with advanced ovarian cancer, first-line maintenance therapy with rucaparib delays the need for first and second subsequent therapies by roughly a year at each step, according to new data from the phase 3 ATHENA-MONO trial. Among...